Kukje Pharma Co Ltd (002720) — Cash Flow Reinvestment Rate
Kukje Pharma Co Ltd (002720) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting ₩474.52 Million (capex ₩474.52 Million ) from operating cash flow of ₩4.99 Billion. See Kukje Pharma Co Ltd (002720) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kukje Pharma Co Ltd Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Kukje Pharma Co Ltd across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Kukje Pharma Co Ltd.
Annual Cash Flow Reinvestment Rate for Kukje Pharma Co Ltd (2011–2024)
Year-by-year capital reinvestment analysis for Kukje Pharma Co Ltd. See 002720 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.20x | ₩4.74 Billion | ₩3.94 Billion | ₩2.99 Billion | ▲ +248.0% |
| 2023 | 0.35x | ₩1.24 Billion | ₩3.58 Billion | ₩1.05 Billion | ▼ -13.7% |
| 2022 | 0.40x | ₩2.61 Billion | ₩6.50 Billion | ₩1.26 Billion | ▲ +18.2% |
| 2021 | 0.34x | ₩3.25 Billion | ₩9.60 Billion | ₩1.89 Billion | ▼ -87.5% |
| 2020 | 2.71x | ₩13.80 Billion | ₩5.10 Billion | ₩11.60 Billion | ▲ +39.2% |
| 2019 | 1.94x | ₩7.01 Billion | ₩3.60 Billion | ₩5.89 Billion | ▲ +510.6% |
| 2018 | 0.32x | ₩4.22 Billion | ₩13.25 Billion | ₩3.03 Billion | ▼ -94.4% |
| 2017 | 5.65x | ₩4.44 Billion | ₩786.10 Million | ₩2.61 Billion | ▲ +1090.8% |
| 2016 | 0.47x | ₩7.63 Billion | ₩16.10 Billion | ₩2.69 Billion | ▼ -52.8% |
| 2012 | 1.00x | ₩1.59 Billion | ₩1.58 Billion | ₩1.59 Billion | ▲ +1641.9% |
| 2011 | 0.06x | ₩1.00 Billion | ₩17.39 Billion | ₩1.00 Billion | — |